Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/81907
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDodd, Caitlin N.en
dc.contributor.author... et al.en
dc.contributor.authorGlobal H1N1 GBS Consortiumen
dc.contributor.otherMarshall, Helen Siobhanen
dc.date.issued2013en
dc.identifier.citationVaccine, 2013; 31(40):4448-58en
dc.identifier.urihttp://hdl.handle.net/2440/81907-
dc.descriptionGlobal H1N1 GBS Consortium contributor: Helen Marshallen
dc.description.statementofresponsibilityCaitlin N. Dodd ... et al. the Global H1N1 GBS Consortiumen
dc.publisherElsevieren
dc.rightsCopyright © 2013 Elsevier Ltd.en
dc.subjectGuillain Barré Syndrome (GBS); Monovalent H1N1 Vaccine (H1N1); Self-controlled case-series method (SCCS); International; Adjuvant; Adverse events following immunization (AEFI)en
dc.titleInternational collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesen
dc.title.alternativeInternational collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesen
dc.typeJournal articleen
dc.contributor.schoolSchool of Paediatrics and Reproductive Health : Paediatricsen
dc.contributor.departmentFaculty of Health Sciencesen
dc.contributor.organisationRobinson Instituteen
dc.identifier.doi10.1016/j.vaccine.2013.06.032en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.